ntg

47
Powerpoint Templates

Upload: ajeng-titi

Post on 30-Jan-2016

15 views

Category:

Documents


0 download

DESCRIPTION

NGT

TRANSCRIPT

Page 1: NTG

Powerpoint Templates

Page 2: NTG

Inspection and Certifications received:

c-GMP – German Federal Health Agency (2010)

c-GMP – TGA (2009)

ISO 9001:2008 (2009)

c-GMP - UK MHRA (2008)

Indonesian GMP (CPOB) – BPOM (Nov 2002)

Successful Audits from Alliances:

UCB - Aug 2006 GSK - Mar 2004

Santen - Jan 2004 Novartis - Nov 2003

Actavis - Sep 2003

Page 3: NTG

Congratulations for PT Ferron Par Pharmaceuticals!

Page 4: NTG

The CVD Continuum

Chrysant SG, World J Cardiol 2010 March 26; 2(3): 43-49

Page 5: NTG

Global CVD Mortality

http://www.who.int/cardiovascular_diseases/en/ ; http://www.world-heart-federation.org/cardiovascular-health/global-facts-map/

Page 6: NTG

Ischemic Heart Disease Mortality

http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf?ua=1

Indonesia: Mortality Rate 109-151 case per 100.000

Page 7: NTG
Page 8: NTG

RISKESDAS 2013

Page 9: NTG

Powerpoint Templates

Page 10: NTG

Thomas Münzel et al. Circulation. 2011;123:2132-2144

Page 11: NTG

Acute Coronary Syndrome• Acute coronary syndrome (ACS) refers to a spectrum of

clinical presentations ranging from those for ST-segment elevation myocardial infarction (STEMI) to presentations found in non–ST-segment elevation myocardial infarction (NSTEMI) or in unstable angina.

• It is almost always associated with rupture of an atherosclerotic plaque and partial or complete thrombosis of the infarct-related artery.

http://emedicine.medscape.com/article/1910735-overview

Page 12: NTG

Unstable Angina, NSTEMI, and STEMI differ with regard to duration, severity, and treatments

Overbaugh KJ. AJN t May 2009 t Vol. 109, No. 5

Page 13: NTG

Mechanism of ActionNitroglycerine

FAST and POWERFUL…

Page 14: NTG

Action of Nitrates on Circulation

The major effect is on the venous capacitance vessels, with additional coronary and peripheral arteriolar vasodilatory benefit

Opie LH & Horowitz JD. Nitrates and newer antianginals. In: Drugs for the Heart. 7 th ed. Saunders Elsevier. China

Page 15: NTG

Nitrates Mechanism

Effects of nitrates in generating NO and stimulating guanylate cyclase to cause a vasodilation

Opie LH & Horowitz JD. Nitrates and newer antianginals. In: Drugs for the Heart. 7 th ed. Saunders Elsevier. China

Page 16: NTG

Clinical Efficacy

FAST and POWERFUL…

Page 17: NTG

Low-dose NTG significantly reduces cardiac filling pressures and improves microvascular perfusion in patients admitted for acute heart failure

Page 18: NTG

Nitroglycerin in acute heart failure

Corstiaan A, et al. European Journal of Heart Failure (2009) 11, 386–390

Page 19: NTG

IV Nitroglycerin is highly effective in preventing adverse ischemic events (reccurent or refractory angina) in patients with unstable angina secondary to restenosis

Page 20: NTG
Page 21: NTG

Perioperative hypertension

Varon J, Malik PE. Vascular Health and Risk Management 2008:4(3) 615–627

Page 22: NTG

Perioperative nitroglycerin

ISDN was successful in treating hypertension in 63% of the events, whereas NTG had an 83% success. NTG has been found to be effective in controlling hypertension

Page 23: NTG
Page 24: NTG

Guidelines Nitroglycerin

FAST and POWERFUL…

Page 25: NTG

ANGINA

Page 26: NTG

2013 ESC guidelines on the management of stable coronary artery disease, European Heart Journal (2013) 34, 2949–3003

Page 27: NTG

STEMI

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, Circulation. 2013;127:e362-e425

Page 28: NTG

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, Circulation. 2013;127:e362-e425

Page 29: NTG

2013 ACCF/AHA Guideline for the Management of Heart Failure, Circulation. 2013;128:e240-e327

HEARTFAILURE

Page 30: NTG

2013 ACCF/AHA Guideline for the Management of Heart Failure, Circulation. 2013;128:e240-e327

Page 31: NTG

Scottish Intercollegiate Guidelines Network (SIGN). Acute coronary syndromes. Edinburgh: SIGN; 2013. (SIGN publication no. 93). [February 2013]. Available from URL: http://www.sign.ac.uk

Page 32: NTG

Product Profile

FAST and POWERFUL…

Page 33: NTG

Farmakokinetik Nitroglycerin• Distribusi luas di dalam tubuh, VD: 200 L• Konsentrasi plasma terapetik 0,1-3 ng/ml (sd 5

ng/ml)• Nitroglycerin terikat 60% protein plasma, metabolit

1,3-glyceryl dinitrate 60%, 1,2-glyceryl dinitrate 30%• Onset 1-2 menit IV• Durasi 3-5 menit, • Waktu paruh 1-4 menit

Page 34: NTG

Indikasi NTG• Gagal jantung yang tidak responsif karena infark

miokard akut• Angina tidak stabil yang sulit disembuhkan dengan

beta blocker dan nitrat sublingual• Pembedahan

– Mengontrol hipertensi dengan cepat selama pembedahan jantung

– Menurunkan tekanan darah dan menjaga hipotensi yang terkontrol selama prosedur pembedahan

– Mengontrol iskemia miokard selama dan setelah pembedahan

Page 35: NTG

DosisIndikasi Dosis Awal Dosis selanjutnya

Pembedahan 25 µg/menit (untuk mengontrol hipertensi )

Kenaikan dosis 25 µg/menit setiap 5 menit hingga tekanan darah stabil

Pengobatan iskemia miokard perioperatif

15-20 µg/menit Kenaikan dosis 10-15 µg/menit hingga efek yang diharapkan tercapai

Gagal jantung kongestif yang tidak responsif

20-25 µg/menit Dapat dikurangi menjadi 10 µg/menit atau ditingkatkan bertahap 20-25 µg/menit tiap 15-30 menit sampai efek yang diharapkan tercapai

Angina tidak stabil 10 µg/menit Kenaikan dosis 10 µg/menit dengan interval 30 menit sesuai dengan kebutuhan pasien

Page 36: NTG

Cara Pemberian

• NTG harus diencerkan sebelum pemberian IV, Campuran pelarut yang

sesuai: 5% dextrose atau 0,9 % sodium chloride injection (NaCl)• Campuran disiapkan dengan cara mengganti volume nitroglycerin dengan

volume yang sama dari larutan pembawa (misal: 10 mg/50 cc ) • NTG: isotonis dan kompatibel dengan larutan infus yang umumnya

digunakan. Tidak ada inkompatibilitas• Kompatibel dengan botol infus gelas, polyethylene, pompa syringe, syringe

plastik atau gelas• Nitroglycerine tidak kompatibel dengan bahan PVC (dapat terjadi

kehilangan zat aktif dalam jumlah banyak <40%) & polyurethan• Hemodinamik dipantau selama pemberian

Page 37: NTG

Konsentrasi Laju infus

100 µg/ml, 5x10 ml ampul NTG IV dalam 500 ml

Mikrotetes/menitml/jam

Tetes/menit

Dosis (µg/menit)

10 6 2

20 12 4

30 18 6

40 24 8

50 30 10

60 36 12

70 42 14

80 48 16

90 54 18

100 60 20

110 66 22

120 72 24

130 78 26

140 84 28

150 90 30

Page 38: NTG

Peringatan dan Perhatian• Monitoring ketat denyut nadi dan tekanan darah• Pasien menderita hipotiroid, penyakit ginjal dan hati

yang berat, hipotermia dan malnutrisi• Pasien dengan tekanan desakan kapiler paru normal

atau rendah dapat menjadi sensitif khususnya terhadap efek hipotensi

• Masa kehamilan dan menyusui• Kemanan dan efikasi pada anak belum diketahui

Page 39: NTG

Efek Samping• Sistem saraf: sakit kepala, pusing• Saluran cerna: mual, muntah dan nyeri abdomen• Jantung: hipotensi, takikardia, palpitasi, bradikardia

paradoksial• Lain-lain: diaforesis, ketakutan, kekelahan, rasa tidak

nyaman, retrosternal, kejang otot

Page 40: NTG

Interaksi Obat• Obat penurun tekanan darah seperti: beta blocker,

antagonis kalsium, vasodilator• Alkohol meningkatkan efek nitroglycerin• Efek hipontensif disebabkan oleh obat-obat sbb:

sidenafil, tadalafil, vardenafil, neuroleptik dan antidepresan trisiklik

Page 41: NTG

Overdosis

• OD ringan: hipotensi dan takikardia– Jika tekanan sistolik turun dibawah 90 mmHg dan

denyut jantung meningkat 10% dari nilai awalnya infus sebaiknya dihentikan

– Jika hipotensi menetap atau pada kasus yang berat, diatasi dengan mengangkat kaki dan atau memberikan obat yang meningkatkan tekanan darah atau menghentikan infus

• OD Berat: pemberian methoxamine atau phenylephrine IV

Page 42: NTG

Summary

• FAST ACTING : Fast onset in 1 minutes• POWERFUL : Strong vasodilator• Recommended by Guidelines• Cost effective

Page 43: NTG

Powerpoint Templates

Hypertensive emergency

Large elevations in SBP or DBP (>180 mmHg or >120 mmHg, respectively) associated with impending or progressive OD, such as major neurological changes, hypertensive encephalopathy, cerebral infarction, intracranial haemorrhage, acute LV failure, acute pulmonary oedema, aortic dissection, renal failure, or eclampsia.

Page 44: NTG

Powerpoint Templates

Page 45: NTG

Powerpoint Templates

NICAFERComposition:

Each ampoule (10 ml) contains nicardipine HCl

1 mg/ml

Indications:

• Emergency treatment of acute hypertensive crises during surgery

• Hypertensive emergencies

Page 46: NTG

Powerpoint Templates

Page 47: NTG

Thank You